Alternatively activated antigen-presenting cells: Molecular repertoire, immune regulation, and healing

被引:57
作者
Gratchev, A [1 ]
Schledzewski, K [1 ]
Guillot, P [1 ]
Goerdt, S [1 ]
机构
[1] Univ Heidelberg, Med Ctr Mannheim, Dept Dermatol, D-6800 Mannheim, Germany
来源
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY | 2001年 / 14卷 / 05期
关键词
antigen-presenting cell polarization; alternatively activated macrophages; immature myeloid dendritic cells; lymphoid dendritic cells; tolerance; downregulation of inflammation; induction of Th2;
D O I
10.1159/000056357
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The Th1/Th2 paradigm has stimulated extensive research into the mechanisms underlying T-cell polarization; alternative activation of antigen-presenting cells (APCs) has turned out to be the corresponding concept APC polarization. Macrophages (M phi) as well as dendritic cells (DCs) can undergo Th1- or Th2-like polarization; APC1 and APC2 thus acquire the capacity to drive the development of naive T cells and the reactivation of resting T cells towards either a Th1 or a Th2 phenotype, respectively. Among polarized APC, effector macrophages are classically activated by mediators such as IFN-gamma, TNF-alpha or LPS (M phi1), while M phi2 are alternatively activated by IL-4, IL-10 or PGE(2). M phi2 exhibit a unique molecular repertoire including receptors of innate immunity with broad specificity for foreign antigen and anti-inflammatory cytokines such as IL-1 receptor antagonist and alternative macrophage activation-associated CC-chemokine (AMAC)-1. While DC1 are well characterized, contradictory results have been obtained for DC2 that may either represent immature myeloid DCs or lymphoid DCs. Altogether, APC2 have come to age; they mediate Th2 differentiation, tolerance induction, downregulation of inflammation and healing. Thus, APC2 represent a hitherto neglected, but indispensable major pathway of APC activation and function. Copyright (C) 2001 S. KargerAG, Basel.
引用
收藏
页码:272 / 279
页数:8
相关论文
共 50 条
[41]  
SNIJDEWINT FGM, 1993, J IMMUNOL, V150, P5321
[42]   GENE-EXPRESSION OF MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA FROM HUMAN BLOOD MONOCYTES AND ALVEOLAR MACROPHAGES IS INHIBITED BY INTERLEUKIN-4 [J].
STANDIFORD, TJ ;
KUNKEL, SL ;
LIEBLER, JM ;
BURDICK, MD ;
GILBERT, AR ;
STRIETER, RM .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1993, 9 (02) :192-198
[43]   INTERLEUKIN-4 POTENTLY ENHANCES MURINE MACROPHAGE MANNOSE RECEPTOR ACTIVITY - A MARKER OF ALTERNATIVE IMMUNOLOGICAL MACROPHAGE ACTIVATION [J].
STEIN, M ;
KESHAV, S ;
HARRIS, N ;
GORDON, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (01) :287-292
[44]  
Steinbrink K, 1997, J IMMUNOL, V159, P4772
[45]   Low zone tolerance to contact allergens in mice: A functional role for CD8(+) T helper type 2 cells [J].
Steinbrink, K ;
Sorg, C ;
Macher, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :759-768
[46]  
SZABOLCS P, 1995, J IMMUNOL, V154, P5851
[47]   DIFFERENTIAL DISTRIBUTION OF INTERCELLULAR-ADHESION MOLECULES (ICAM-1, ICAM-2, AND ICAM-3) AND THE MS-1 ANTIGEN IN NORMAL AND DISEASED HUMAN SYNOVIA - THEIR POSSIBLE PATHOGENETIC AND CLINICAL-SIGNIFICANCE IN RHEUMATOID-ARTHRITIS [J].
SZEKANECZ, Z ;
HAINES, GK ;
LIN, TR ;
HARLOW, LA ;
GOERDT, S ;
RAYAN, G ;
KOCH, AE .
ARTHRITIS AND RHEUMATISM, 1994, 37 (02) :221-231
[48]  
WALSH LJ, 1991, LAB INVEST, V65, P732
[49]   Oral tolerance: Immune mechanisms and treatment of autoimmune diseases [J].
Weiner, HL .
IMMUNOLOGY TODAY, 1997, 18 (07) :335-343
[50]   A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells [J].
Whelan, M ;
Harnett, MM ;
Houston, KM ;
Patel, V ;
Harnett, W ;
Rigley, KP .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6453-6460